Tulavi Therapeutics
Mountain View, US · Founded 2018 · Delaware corporation · 2 known investors
Tulavi develops medical devices for peripheral nerve surgery, aiming to improve surgical treatment options and patient outcomes in nerve care. The company builds tools intended for surgical use to address gaps in current treatments.
HardwareHealthtechMedical Devices
Founders & leadership
Tulavi Therapeutics was founded in 2018 by Farhad Khosravi and Fred Khosravi.
FK
Farhad KhosraviCo-founder
FK
Fred KhosraviChairman & Co-Founder
JV
Josh VoseChief Executive Officer
CB
Corinne BrightNamed on SEC filing
Board
HC
Investors · 2
Reported raises · per SEC filings
Form D private placements$14.5M disclosed across 4 rounds · 2018–2021
▶$1MraisedDec 2021 · 9 investors · BiotechnologyRule 506(b)
▶$1MraisedDec 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Corinne BrightExecutive Officer, Director
- Farhad KhosraviDirector
- Henry ChenDirector
- Amar SawhneyDirector
- Steve WillamsonDirector
- Tara ButlerDirector
- Greg CasciaroDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$7.5MraisedMar 2021 · 3 investors · BiotechnologyRule 506(b)
▶$7.5MraisedMar 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Farhad KhosraviDirector
- Henry ChenDirector
- Amar SawhneyDirector
- Steve WillamsonDirector
- Tara ButlerDirector
- Corinne BrightExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $7.5M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3MraisedMay 2020 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedMay 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Farhad KhosraviDirector
- Amar SawneyDirector
- Corinne BrightExecutive Officer, Director
- Henry ChenDirector
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3MraisedDec 2018 · 3 investors · Other Health CareRule 506(c)
▶$3MraisedDec 2018 · 3 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Henry ChenDirector
- Corinne BrightExecutive Officer, Director
- Farhad KhosraviExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3M
- Minimum investment
- $160K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Globus Medical3 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Noctrix Health3 shared keywordsNoctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes. The company targets patients living with chronic conditions such as restless legs syndrome, offering prescription-grade therapy through medical devices.
Power3 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Massdevice3 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Companies competing with Tulavi Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Tulavi Therapeutics do?
- Tulavi develops medical devices for peripheral nerve surgery, aiming to improve surgical treatment options and patient outcomes in nerve care. The company builds tools intended for surgical use to address gaps in current treatments.
- Who founded Tulavi Therapeutics?
- Tulavi Therapeutics was founded by Farhad Khosravi, Fred Khosravi in 2018.
- Who are Tulavi Therapeutics's investors?
- Tulavi Therapeutics's investors include Ascension Ventures, Delos Capital.
- How much funding has Tulavi Therapeutics raised?
- Tulavi Therapeutics has disclosed $14.5M raised across 4 rounds.
- Where is Tulavi Therapeutics headquartered?
- Tulavi Therapeutics is headquartered in Mountain View, US.